Health· 2 hours agoHigh-Dose Vitamin B3 Shows Early Promise Against Glioblastoma in Small Calgary TrialIn an interim analysis of a University of Calgary trial, 82% of 24 glioblastoma patients given controlled-release niacin alongside standard treatment had no cancer progression after six months. The researchers stress the results are preliminary.
